These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 457294)

  • 61. Interaction between I region loci influences the expression of a cell surface Ia antigen.
    Murphy DB; Jones PP; Loken MR; McDevitt HO
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5404-8. PubMed ID: 6776536
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.
    Lisowska-Grospierre B; Charron DJ; de Préval C; Durandy A; Griscelli C; Mach B
    J Clin Invest; 1985 Jul; 76(1):381-5. PubMed ID: 3860509
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HLA-DR typing by radioimmunoassay.
    Tosi R; Tanigaki N; Centis D; Rossi PL; Alfano G; Ferrara GB; Pressman D
    Transplantation; 1980 Apr; 29(4):302-5. PubMed ID: 7368279
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans.
    Beer AE; Quebbeman JF; Ayers JW; Haines RF
    Am J Obstet Gynecol; 1981 Dec; 141(8):987-99. PubMed ID: 6459031
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of new cell surface markers in man: the problem of immunogenicity.
    Ferrara GB
    Transplant Proc; 1979 Mar; 11(1):715-8. PubMed ID: 313101
    [No Abstract]   [Full Text] [Related]  

  • 66. Isolation of a human major histocompatibility complex class I gene encoding a nonubiquitous molecule expressed on activated lymphocytes.
    Paul P; Fauchet R; Boscher MY; Sayagh B; Masset M; Medrignac G; Dausset J; Cohen D
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2872-6. PubMed ID: 3033667
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of I-J-subregion gene products in the regulation of macrophage-T-Lymphocyte interaction.
    Niederhuber JE; Allen PM; Mayo L
    Transplant Proc; 1979 Mar; 11(1):727-31. PubMed ID: 88100
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon.
    Pober JS; Collins T; Gimbrone MA; Cotran RS; Gitlin JD; Fiers W; Clayberger C; Krensky AM; Burakoff SJ; Reiss CS
    Nature; 1983 Oct 20-26; 305(5936):726-9. PubMed ID: 6415484
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The ELY-1 locus controls a di-allelic alloantigenic system on equine lymphocytes.
    Byrns G; Crump AL; Lalonde G; Bernoco D; Antczak DF
    J Immunogenet; 1987 Feb; 14(1):59-71. PubMed ID: 3655400
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IFN-induced modulation of histocompatibility antigens on human cells. Background, mechanisms and perspectives.
    Hokland M; Basse P; Justesen J; Hokland P
    Cancer Metastasis Rev; 1988 Nov; 7(3):193-207. PubMed ID: 2465842
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure of the HLA-D region.
    Itakura K
    Microbiol Immunol; 1979; 23(11):1133-9. PubMed ID: 316852
    [No Abstract]   [Full Text] [Related]  

  • 74. The potential of the I region of the bovine major histocompatibility complex.
    Adams TE; Brandon MR; Morris B
    Anim Blood Groups Biochem Genet; 1979; 10(3):155-63. PubMed ID: 391107
    [No Abstract]   [Full Text] [Related]  

  • 75. Immunological Involvement of MicroRNAs in the Key Events of Systemic Lupus Erythematosus.
    Chi M; Ma K; Li Y; Quan M; Han Z; Ding Z; Liang X; Zhang Q; Song L; Liu C
    Front Immunol; 2021; 12():699684. PubMed ID: 34408748
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interferon pathway in SLE: one key to unlocking the mystery of the disease.
    Rönnblom L; Leonard D
    Lupus Sci Med; 2019; 6(1):e000270. PubMed ID: 31497305
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cell cycle and the differential expression of HLA-A,B and HLA-DR antigens on human B lymphoid cells.
    Sarkar S; Glassy MC; Ferrone S; Jones OW
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7297-301. PubMed ID: 6971443
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biosynthetic human interferon treatment of herpetic keratitis.
    Smolin G
    Trans Am Ophthalmol Soc; 1983; 81():785-824. PubMed ID: 6676984
    [No Abstract]   [Full Text] [Related]  

  • 79. Virus-induced decrease of insulin receptors in cultured human cells.
    Shimizu F; Hooks JJ; Kahn CR; Notkins AL
    J Clin Invest; 1980 Nov; 66(5):1144-51. PubMed ID: 6253524
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interferon increases HLA synthesis in melanoma cells: interferon-resistant and -sensitive cell lines.
    Basham TY; Bourgeade MF; Creasey AA; Merigan TC
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3265-9. PubMed ID: 6179079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.